{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:30:52Z","timestamp":1786991452882,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007416","name":"Swedish Brain Power","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009673","name":"Gun och Bertil Stohnes Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jamda.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jamda.2018.12.019","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:10:36Z","timestamp":1551208236000},"page":"323-329.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Antipsychotic Treatment Associated With Increased Mortality Risk in Patients With Dementia. A Registry-Based Observational Cohort Study"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-7475","authenticated-orcid":false,"given":"Emilia","family":"Schwertner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1532-3967","authenticated-orcid":false,"given":"Juraj","family":"Secnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1537-6129","authenticated-orcid":false,"given":"Sara","family":"Garcia-Ptacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0194-8402","authenticated-orcid":false,"given":"Katarina","family":"Nagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Eriksdotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4583-4570","authenticated-orcid":false,"given":"Dorota","family":"Religa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2018.12.019_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jamda.2018.12.019_bib2","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1017\/S1041610211002924","article-title":"Dementia time to death: A systematic literature review on survival time and years of life lost in people with dementia","volume":"24","author":"Brodaty","year":"2012","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2018.12.019_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3233\/JAD-131856","article-title":"Mortality risk after dementia diagnosis by dementia type and underlying factors: A cohort of 15,209 patients based on the Swedish Dementia Registry","volume":"41","author":"Garcia-Ptacek","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2018.12.019_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10072-006-0716-6","article-title":"Survival among elderly Italian patients with dementia treated with atypical antipsychotics: Observational study","volume":"27","author":"Nonino","year":"2006","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jamda.2018.12.019_bib5","doi-asserted-by":"crossref","first-page":"447.e1","DOI":"10.1016\/j.jamda.2014.03.001","article-title":"Body mass index and mortality in incident dementia: A cohort study on 11,398 patients from SveDem, the Swedish Dementia Registry","volume":"15","author":"Garc\u00eda-Ptacek","year":"2014","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2018.12.019_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1474-4422(08)70295-3","article-title":"The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomised placebo-controlled trial","volume":"8","author":"Ballard","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2018.12.019_bib7","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1017\/S1041610213000859","article-title":"Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings","volume":"25","author":"Gustafsson","year":"2013","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2018.12.019_bib8","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","article-title":"Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study","volume":"288","author":"Lyketsos","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2018.12.019_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1017\/S1041610205001523","article-title":"The impact of neuropsychiatric symptoms of dementia on distress in family and professional caregivers in Singapore","volume":"17","author":"Tan","year":"2005","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2018.12.019_bib10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1176\/ajp.147.8.1049","article-title":"Psychiatric symptoms and nursing home placement of patients with Alzheimer\u2019s disease","volume":"147","author":"Steele","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2018.12.019_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/gerona\/58.6.M548","article-title":"Presence of behavioral and psychological symptoms predicts nursing home placement in community-dwelling elders with cognitive impairment in univariate but not ultivariate analysis","volume":"58","author":"Chan","year":"2003","journal-title":"J\u00a0Gerontol Ser A"},{"key":"10.1016\/j.jamda.2018.12.019_bib12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.62.10.1601","article-title":"Delusions and hallucinations are associated with worse outcome in Alzheimer disease","volume":"62","author":"Scarmeas","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jamda.2018.12.019_bib13","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2018.12.019_bib14","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa052827","article-title":"Risk of death in elderly users of conventional vs atypical antipsychotic medications","volume":"353","author":"Wang","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2018.12.019_bib15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/0003-4819-146-11-200706050-00006","article-title":"Antipsychotic drug use and mortality in older adults with dementia","volume":"146","author":"Gill","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2018.12.019_bib16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1176\/appi.ajp.2013.12081046","article-title":"The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer\u2019s disease","volume":"170","author":"Lopez","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2018.12.019_bib17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/JGP.0b013e31802d0b00","article-title":"Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: A two-year prospective study","volume":"15","author":"Raivio","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2018.12.019_bib18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/156720512803569037","article-title":"Antipsychotic use and mortality risk in community-dwelling Alzheimer\u2019s disease patients: Evidence for a role of dementia severity","volume":"9","author":"Gardette","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.jamda.2018.12.019_bib19","doi-asserted-by":"crossref","first-page":"464.e1","DOI":"10.1016\/j.jamda.2016.01.016","article-title":"Antipsychotic drug use is not associated with long-term mortality risk in Norwegian nursing home patients","volume":"17","author":"Selb\u00e6k","year":"2016","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2018.12.019_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jamda.2015.03.015","article-title":"The mortality risk of conventional antipsychotics in elderly patients: A systematic review and meta-analysis of randomized placebo-controlled trials","volume":"16","author":"Hulshof","year":"2015","journal-title":"J\u00a0Am Med Dir Asso"},{"key":"10.1016\/j.jamda.2018.12.019_bib21","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer\u2019s disease","volume":"355","author":"Schneider","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2018.12.019_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11096-017-0555-y","article-title":"Efficacy and safety of atypical antipsychotics for behavioral symptoms of dementia among patients residing in long-term care","volume":"40","author":"Sturm","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jamda.2018.12.019_bib23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/gps.4101","article-title":"Associations between risk of mortality and atypical antipsychotic use in vascular dementia: A clinical cohort study: Antipsychotics and mortality in vascular dementia","volume":"29","author":"Sultana","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2018.12.019_bib24","doi-asserted-by":"crossref","first-page":"e0116538","DOI":"10.1371\/journal.pone.0116538","article-title":"SveDem, the Swedish dementia registry\u2014A tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice","volume":"10","author":"Religa","year":"2015","journal-title":"PLOS One"},{"key":"10.1016\/j.jamda.2018.12.019_bib25","series-title":"The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines","year":"1992"},{"key":"10.1016\/j.jamda.2018.12.019_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB International Workshop","volume":"9","author":"McKeith","year":"2006","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2018.12.019_bib27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","article-title":"Clinical and neuropathological criteria for frontotemporal dementia","volume":"57","author":"Brun","year":"1994","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jamda.2018.12.019_bib28","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.jamda.2018.12.019_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A\u00a0note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jamda.2018.12.019_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chroni Dis"},{"key":"10.1016\/j.jamda.2018.12.019_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000109756","article-title":"Cognitive impairment in Parkinson\u2019s disease and dementia with Lewy bodies: A spectrum of disease","volume":"16","author":"Goldmann Gross","year":"2008","journal-title":"Neurosignals"},{"key":"10.1016\/j.jamda.2018.12.019_bib32","series-title":"A\u00a0Package for Survival Analysis in S. version 2.38","author":"Therneau","year":"2015"},{"key":"10.1016\/j.jamda.2018.12.019_bib33","series-title":"A\u00a0language and environment for statistical computing","year":"2013"},{"key":"10.1016\/j.jamda.2018.12.019_bib34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4088\/JCP.v66n0514","article-title":"Neuroleptic sensitivity in Parkinson\u2019s disease and Parkinsonian dementias","volume":"66","author":"Aarsland","year":"2005","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jamda.2018.12.019_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.305.6855.673","article-title":"Neuroleptic sensitivity in patients with senile dementia of Lewy body type","volume":"305","author":"McKeith","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2018.12.019_bib36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0006-3223(98)00127-9","article-title":"Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: Comparisons with Parkinson\u2019s disease","volume":"44","author":"Piggott","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jamda.2018.12.019_bib37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3233\/JAD-151207","article-title":"Association between antipsychotic drugs and mortality in older persons with Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"52","author":"Zhai","year":"2016","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2018.12.019_bib38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/acps.12614","article-title":"Cumulative dosages of antipsychotic drugs are associated with increased mortality rate in patients with Alzheimer\u2019s dementia","volume":"134","author":"Nielsen","year":"2016","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jamda.2018.12.019_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YIC.0000000000000146","article-title":"Risk excess of mortality and use of antipsychotics: A case\u2013noncase study","volume":"32","author":"Mart\u00edn Arias","year":"2017","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jamda.2018.12.019_bib40","first-page":"15","article-title":"Movement disorders associated with neuroleptic treatment","volume":"62","author":"Wirshing","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jamda.2018.12.019_bib41","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/archinte.165.16.1882","article-title":"Atypical Antipsychotics and Parkinsonism","volume":"165","author":"Rochon","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2018.12.019_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vph.2017.09.001","article-title":"Effects of psychopharmacological treatment with antipsychotic drugs on the vascular system","volume":"100","author":"Kahl","year":"2018","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.jamda.2018.12.019_bib43","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archinte.165.6.696","article-title":"Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest","volume":"165","author":"Liperoti","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2018.12.019_bib44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14740330903117271","article-title":"Risk of venous thromboembolism due to antipsychotic drug therapy","volume":"8","author":"H\u00e4gg","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jamda.2018.12.019_bib45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.21037\/atm.2018.03.17","article-title":"Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders","volume":"6","author":"Aronow","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jamda.2018.12.019_bib46","first-page":"1186","article-title":"Olanzapine as a possible treatment of behavioral symptoms in vascular dementia: Risks of cerebrovascular events","volume":"252","author":"Moretti","year":"2005","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jamda.2018.12.019_bib47","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1212\/WNL.0b013e3182a35151","article-title":"Risk of incident stroke in patients with Alzheimer disease or vascular dementia","volume":"81","author":"Imfeld","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2018.12.019_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1479-8301.2011.00396.x","article-title":"Altered risk-aversion and risk-taking behaviour in patients with Alzheimer\u2019s disease: Risky behaviour in Alzheimer\u2019s patients","volume":"12","author":"Ha","year":"2012","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.jamda.2018.12.019_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-2010-101836","article-title":"Predicting disease progression in Alzheimer\u2019s disease: The role of neuropsychiatric syndromes on functional and cognitive decline","volume":"24","author":"Palmer","year":"2011","journal-title":"J\u00a0Alzheimer Dis"},{"key":"10.1016\/j.jamda.2018.12.019_bib50","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0706743716673321","article-title":"Antipsychotic use in dementia","volume":"62","author":"Kirkham","year":"2017","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.jamda.2018.12.019_bib51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/2050-6511-14-56","article-title":"Psychotropic drug use among people with dementia\u2014A six-month follow-up study","volume":"14","author":"Gustafsson","year":"2013","journal-title":"BMC Pharmacol Toxicol"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101830728X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101830728X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T11:43:10Z","timestamp":1565178190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152586101830728X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S152586101830728X"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2018.12.019","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic Treatment Associated With Increased Mortality Risk in Patients With Dementia. A Registry-Based Observational Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2018.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}